rs149980411

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152393.4(KLHL40):​c.1738C>A​(p.Leu580Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,610,860 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00099 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 44 hom. )

Consequence

KLHL40
NM_152393.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.04

Publications

6 publications found
Variant links:
Genes affected
KLHL40 (HGNC:30372): (kelch like family member 40) This gene encodes a protein containing a BACK domain, a BTB/POZ domain, and 5 Kelch repeats, however, its exact function is not known. The gene and the multi-domain protein structure are conserved across different taxa, including primates, rodents, chicken and zebrafish. [provided by RefSeq, Dec 2012]
KLHL40 Gene-Disease associations (from GenCC):
  • nemaline myopathy 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009362847).
BP6
Variant 3-42690989-C-A is Benign according to our data. Variant chr3-42690989-C-A is described in ClinVar as Benign. ClinVar VariationId is 262642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000985 (150/152244) while in subpopulation SAS AF = 0.0208 (100/4818). AF 95% confidence interval is 0.0175. There are 3 homozygotes in GnomAd4. There are 94 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLHL40NM_152393.4 linkc.1738C>A p.Leu580Ile missense_variant Exon 5 of 6 ENST00000287777.5 NP_689606.2 Q2TBA0-1A8K5H9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLHL40ENST00000287777.5 linkc.1738C>A p.Leu580Ile missense_variant Exon 5 of 6 1 NM_152393.4 ENSP00000287777.4 Q2TBA0-1

Frequencies

GnomAD3 genomes
AF:
0.000979
AC:
149
AN:
152126
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0205
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000515
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00342
AC:
848
AN:
247750
AF XY:
0.00464
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.000176
Gnomad ASJ exome
AF:
0.00257
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.0000468
Gnomad NFE exome
AF:
0.000661
Gnomad OTH exome
AF:
0.00265
GnomAD4 exome
AF:
0.00178
AC:
2593
AN:
1458616
Hom.:
44
Cov.:
31
AF XY:
0.00250
AC XY:
1815
AN XY:
725484
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33428
American (AMR)
AF:
0.000135
AC:
6
AN:
44390
Ashkenazi Jewish (ASJ)
AF:
0.00294
AC:
76
AN:
25832
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39668
South Asian (SAS)
AF:
0.0239
AC:
2048
AN:
85754
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53274
Middle Eastern (MID)
AF:
0.00959
AC:
55
AN:
5736
European-Non Finnish (NFE)
AF:
0.000259
AC:
288
AN:
1110314
Other (OTH)
AF:
0.00198
AC:
119
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
116
233
349
466
582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000985
AC:
150
AN:
152244
Hom.:
3
Cov.:
32
AF XY:
0.00126
AC XY:
94
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41540
American (AMR)
AF:
0.000261
AC:
4
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.0208
AC:
100
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000515
AC:
35
AN:
68010
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000864
Hom.:
2
Bravo
AF:
0.000506
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.00371
AC:
451
Asia WGS
AF:
0.00664
AC:
23
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Dec 13, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nemaline myopathy 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.85
T
MetaRNN
Benign
0.0094
T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
1.8
L
PhyloP100
3.0
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-0.28
N
REVEL
Benign
0.27
Sift
Benign
0.26
T
Sift4G
Benign
0.21
T
Polyphen
0.0080
B
Vest4
0.44
MVP
0.74
MPC
0.10
ClinPred
0.019
T
GERP RS
2.9
Varity_R
0.24
gMVP
0.29
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149980411; hg19: chr3-42732481; API